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Abstract
Background: Cell-in-cell structures (caused by cell cannibalistic activity) have been related to prognosis of many
cancers. This is the first multi-institutional study to assess the prognostic impact of cell-in-cell structures in a large
cohort of early oral tongue squamous cell carcinomas (OTSCC).
Methods: A total of 308 cases from five Finnish University Hospitals and from the A.C. Camargo Cancer Center, São
Paulo, Brazil, were included in this study. Cell-in-cell structures were evaluated on surgical postoperative sections
that stained with hematoxylin and eosin staining.
Results: We found that cell-in-cell structures associated with cancer-related mortality in univariable analysis with a
hazard ratio (HR) of 2.99 (95%CI 1.52–5.88; P = 0.001). This association was confirmed in multivariable analysis (HR
2.22, 95%CI 1.12–4.44; P = 0.024). In addition, statistically significant associations were observed between the cell-in-
cell structures and other adverse histopathologic characteristics including deep invasion (P < 0.001), high index of
tumor budding (P = 0.007), worst pattern of invasion (P < 0.001), perineural invasion (P = 0.01), and stroma-rich
pattern (P = 0.001).
Conclusions: Our findings demonstrate a significant relationship between cell-in-cell formation and aggressive
characteristics of early OTSCC. Cell-in-cell structures have a distinct impact as a novel prognostic indicator in early
OTSCC and they can be easily assessed during routine pathology practice.
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Background
Oral cancer constitutes a major health problem with
a global estimation of 354,864 new cases and 177,384
associated deaths in the year 2018 [1]. Oral tongue
squamous cell carcinomas (OTSCC) is the most com-
monly reported carcinoma within the oral cavity and
forms about one third of the diagnosed oral squa-
mous cell carcinomas (OSCC) [2]. The incidence of
OTSCC is increasing in many countries [3]. In
addition, OTSCC associated with the highest cancer-
related mortality compared with OSCC of the other
oral subsites (floor of mouth, buccal mucosa, hard
palate, gum, and retromolar trigone) [2]. Clinical be-
havior in many OTSCCs demonstrates an aggressive
characteristic that associates with a moderate level of
cancer-related mortality even in cases with early diag-
nosis [4]. In this context, many research efforts have
been undertaken to introduce biomarkers that can
help in early diagnosis by identifying oral tumors at
an early stage when the lesion is small (≤ 4 cm in
diameter), superficial and there is not yet metastasis
[5, 6]. Clinically, such early stage tumors are usually
referred to as cT1-T2N0 lesions. However, some of
early-stage OTSCC have aggressive tumor behavior
that requires multimodality treatment on a case-by-
case basis. Unfortunately, it is challenging to identify
those early OTSCC cases that require aggressive
treatment if only conventional prognosticators (e.g.
TNM stage, WHO grade or perineural invasion) are
taken into consideration. Of note, research on prog-
nostic biomarkers of cancer has not yet identified
suitable candidates that could be considered in daily
practice for the management of early OTSCC [7]. In
addition, recent research has introduced new mole-
cules as treatment targets for OTSCC [8, 9], although
they are not yet clinically proven.
Invasion and metastasis are complex processes associ-
ating with cancer progression, and cancer tissues com-
prise dissimilar cell populations with variations in
invasiveness and metastatic potential. Previous research
has identified cellular and tissue prognostic markers re-
lated to characteristics of cancer behavior, such as apop-
tosis and tumor necrosis [7]. On the other hand, the
clinical relevance of other mechanisms of cell death (for
example cell cannibalism) have not been well-elucidated
in early-stage OTSCC.
Cell-in-cell phenomenon/structure (also known as
cell-in-cell formation, cancer cell cannibalism, in-cell in-
vasion, or entosis) was described as a process of non-
apoptotic cell death where one cancer cell surrounds an-
other cancer cell followed by degradation of the internal-
ized cell by lysosomal enzymes [10, 11]. This cell
internalization process is different from phagocytosis as
it is performed by a non-phagocytic cell, and the
internalized cancer cell remains initially alive [12]. This
phenomenon has been reported in various types of epi-
thelial tumors and may promote tumor progression [13].
Histopathologically, a cell-in-cell structure has been de-
fined as a larger cell enclosing a smaller cell within its
cytoplasm. Cancer cell cannibalistic activity has been
established as an important metabolic adaptation of can-
cers in an unfavorable microenvironment that lacking
enough nutrition for cancer cells [13]. In addition, can-
nibalistic behavior has been shown to feed metastatic
cells [13], where cannibalism was performed by meta-
static and not by primary cells of melanoma [14]. It is
noteworthy that the cell-in-cell structure has been well-
known for decades among pathologists, but its clinical
significance has remained neglected. Only recent re-
search has emphasized the significance of the cell-in-cell
phenomenon in the behavior of many cancers [15–17].
However, the clinical relevance of cell-in-cell has not
been well-studied in many cancers of the head and neck
region including early OTSCC.
The aim of the current study is to evaluate the prog-
nostic significance of cell-in-cell structures in predicting
cancer-related mortality in early OTSCC. We also aim
to analyze the relationship between cell-in-cell structures
and aggressive tumor features (e.g. worst pattern of inva-
sion and perineural invasion) of early-stage OTSCC.
Methods
Patients
We included 308 cases treated for early OTSCC (cT1-2
N0) at the five university hospitals in Finland or at the
A.C. Camargo Cancer Center, São Paulo, Brazil. Ethical
approval was obtained from the ethics committees of
each university hospital included and from the Finnish
National Supervisory Authority for Welfare and Health
(VALVIRA). For the Brazilian cases, a permission from
the Brazilian Human Research Ethics Committee was
obtained.
Histopathologic evaluation of cell-in-cell structures
We used the surgical postoperative samples that were
stained with hematoxylin and eosin (HE) for the assess-
ment of cell-in-cell structures (Fig. 1). Cell-in-cell was
defined as a structure consisting of a cancer cell con-
tained inside another larger cancer cell with a crescent-
shaped nucleus [15]. Such structures include also cancer
cells with a morphological appearance of “bird’s-eye
cells” and/or “signet-ring cells”. Low magnification (× 40
and × 100) was used to scan the whole sample. Struc-
tures including an ingested cell dislocating the nucleus
of the other cell to the periphery of the structure were
studied carefully with high magnification (× 200 and
sometimes × 400).
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Two observers (AA, IL) convened for a training ses-
sion where examples of cell-in-cell were introduced by a
researcher (AA), and the interpretation was guided by
an experienced head and neck pathologist (IL). During
the session, a discussion on the various shapes of cell-in-
cell structures was conducted to standardize their recog-
nition by the observers (AA, IL) and to assess randomly
selected cases. The training session was followed by re-
view sessions.
Statistical analysis
We used IBM SPSS Statistics (version 25) for survival
analysis and to calculate the prognostic significance of
cell-in-cell. Univariable and multivariable survivals were
estimated with hazard ratios (HR) and 95% confidence
intervals (CI) using Cox regression. Kaplan-Meier sur-
vival curves were prepared to describe cancer-related
mortality in association with the cell-in-cell
phenomenon. The log-rank test was used to evaluate the
statistical significance between the estimated curves.
Cross-tabulation and chi-square test were used to
analyze the association between cell-in-cell and other
features of aggressive tumor behavior (e.g. tumor bud-
ding, depth of invasion, and tumor-stroma ratio) that we
have evaluated in our previous research [18] (Table 1).
Results
The main clinicopathologic features and their associ-
ation with cell-in-cell phenomenon are summarized in
Table 1. There were 200 tumors (64.9% of all cases) hav-
ing cell-in-cell structures, while 108 (35.1%) had no cell-
in-cell. Inter-observer agreement was good with Kappa
value of 0.74.
The presence of cell-in-cell structures associated sig-
nificantly with tumors with deep invasive growth (≥4
mm) (P < 0.001) and with tumors with a high frequency
of tumor budding (P = 0.007). In addition, cell-in-cell
structures were associated with worst pattern of invasion
(P < 0.001), stroma-rich pattern (P = 0.001), WHO grade
(P = 0.031) and perineural invasion (P = 0.01). We did
not find any significant association between cell-in-cell
structures and patient age (P = 0.397), gender
(P > 0.999) or tumor size (P = 0.113).
Univariable survival analysis showed a statistically sig-
nificant prognostic value for cell-in-cell structures. Early
OTSCC cases that have cell-in-cell structures displayed
a higher rate of cancer-related mortality with a HR of
2.99 and 95% CI of 1.52 to 5.88 (P = 0.001). The prog-
nostic value of cell-in-cell structures was confirmed in
multivariable analysis (HR 2.22, 95% 1.12 to 4.44; P =
0.024) adjusted by age, stage, tumor grade, perineural in-
vasion, worst pattern of invasion and depth of invasion.
The multivariable Cox regression model revealed a sig-
nificant effect of cell-in-cell structures on the survival in-
dependent from factors evaluated routinely (i.e. tumor
grade, perineural invasion, pattern of invasion and depth
of invasion) in pathology practice. In addition, the sig-
nificance of cell-in-cell structures for prognostication of
cancer-related mortality has been clearly shown by log
rank test (P < 0.001) and Kaplan-Meier survival curves
(Fig. 2).
Discussion
The characteristics of invasiveness in each tumor type
and stage vary from case to case. In early-stage OTSCC,
many cases behave like advanced carcinoma and lead to
cancer-related mortality. Moreover, in the same cancer
tissue, cancer cells are also varying in their characteris-
tics as some cells can be more aggressive than others.
Identifying the aggressive cancer cells can help to
recognize aggressive tumors. Cancer cells like unicellular
organisms can engulf whole neighboring cells to scav-
enge for extracellular nutrients [13]. Such cannibalistic
cancer cells have been assessed in this study and were
found to have a significant association with aggressive
behavior of early OTSCC.
The clinical significance of cannibalistic cell-in-cell
structures has been reported in many cancers as an ad-
verse prognostic feature [16, 19, 20]. Cellular cannibal-
ism (i.e. cell-in-cell structures) has been reported
commonly in various cancers but not in normal tissues
[16]. In addition, we found a significant association be-
tween cell-in-cell structures of early OTSCC and other
aggressive histopathologic features that are tumor-
related (e.g. tumor budding and depth of invasion) or
stroma-related (e.g. tumor-stroma ratio) (Fig. 3). More-
over, metastatic cancers have been reported with a
higher occurrence of cell-in-cell structures than non-
metastatic cancers [21]. These facts propose that cellular
cannibalism is a possible hallmark of an aggressive can-
cer. In a cohort of head and neck squamous cell carcin-
omas, Schenker et al. [22] found that formation of cell-
in-cell structures had a superior prognostic value
Fig. 1 Cell-in-cell structures in early-stage oral tongue cancer.
Winner cells (arrows) engulfing loser cells (arrowheads)
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compared to apoptosis or senescence. Furthermore,
Mackay and colleagues [19] reported that cell-in-cell for-
mation was an independent prognostic marker in lung
adenocarcinomas and had an association with the occur-
rence of mutant p53 and genomic instability in these tu-
mors. In pancreatic ductal adenocarcinoma, Hayashi
et al. [15] found that cell-in-cell structures predict prog-
nosis, and associate with poorly-differentiated tumors,
TP53 mutations, KRAS amplification and MYC
amplification.
The mechanism underlying cancer cell cannibalism
is somehow similar to phagocytosis as both processes
can be against the apoptotic cells; however, cannibal-
istic cancer cell engulfs live cancer cells as well [13].
This behavior of the cannibalistic cancer cells and
reasons that induce a cancer cell to invade its neigh-
boring cancer cell has been an area of active investi-
gation for many years. Similar to other cells, cancer
cells need nutrient scavenging from their environment
especially since tumor vasculature is deficient in many
tumors [23]. In addition, cancer cells are known to
compete for nutrients. During the formation of cell-
in-cell structures, the engulfing cell (i.e. winner) can-
nibalizes the engulfed cell (i.e. loser) as an expression
of competition between hungry cancer cells [24].
Moreover, Hamann et al. [25] have reported that the
process of ingesting a neighboring cancer cell is initi-
ated by glucose starvation, allowing for the prolifera-
tion of the winner cell. Thus, in low-nutrient
environments, cannibalism was seen as a mechanism
Table 1 Relationship between cell-in-cell structures and clinicopathologic features in early-stage oral tongue cancer
Variable Total Cell-in-cell P value
of chi-
square
test
None One or more
N = 308 N = 108 N (%) N = 200 N (%)
Age 0.397
≤ 60 128 41 (32.0) 87 (68.0)
> 60 180 67 (37.2) 113 (62.8)
Gender > 0.999
Male 164 58 (35.4) 106 (64.6)
Female 144 50 (34.7) 94 (65.3)
cTNM stage 0.113
T1N0M0 123 50 (40.7) 73 (59.3)
T2N0M0 185 58 (31.4) 127 (68.6)
Grade (WHO) 0.031
Well differentiated 104 46 (44.2) 58 (55.8)
Moderately differentiated 130 36 (27.7) 94 (72.3)
Poorly differentiated 74 26 (35.1) 48 (64.9)
Tumor budding 0.007
Low (< 5 buds) 212 85 (40.1) 127 (59.9)
High (≥5 buds) 98 23 (24.0) 73 (76.0)
Depth of invasion < 0.001
Superficial (< 4 mm) 113 61 (54.0) 52 (46.0)
Deep (≥4 mm) 195 47 (24.1) 148 (75.9)
Worst pattern of invasion < 0.001
Cohesive 77 41 (53.2) 36 (46.8)
Invasive 231 67 (29.0) 164 (71.0)
Tumor-stroma ratio 0.001
Low 220 90 (40.9) 130 (59.1)
High 88 18 (20.5) 70 (79.5)
Perineural invasion 0.010
Absent 267 101 (37.8) 166 (62.2)
Present 41 7 (17.1) 34 (82.9)
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to support the proliferation of cancer cells [23]. Fur-
thermore, Lugini et al. [14] found that cannibalistic
activity increased cell survival of metastatic melan-
oma. Thus, it was speculated that cannibalism is a
method for feeding metastatic cancers [26].
Multivariable analysis of the current cohort showed
that cell-in-cell is an independent prognostic marker
when adjusted for other factors including depth of
invasion, pattern of invasion, tumor grade and peri-
neural invasion. Interestingly, the above mentioned
four parameters are reported often in pathology re-
ports and, in a recent study on early-stage oral
cancer [27], they were recognized as important prog-
nosticators. This indicates that the cell-in-cell struc-
ture is a histopathologic characteristic providing
prognostic information complementary to conven-
tional prognostic features. Furthermore, studies in
other cancers support our findings on the cell-in-cell
structure as an indicator of aggressive behavior in
OTSCC [15, 16, 28–31].
Conclusions
Cell-in-cell structures can be used to identify a sub-
group of patients with an aggressive early-stage
OTSCC with a high rate of cancer-related mortality.
The assessment of cell-in-cell structures can be con-
ducted using HE-stained sections and they can be
used as a new tool to determine the aggressiveness of
early OTSCC. As the cannibalistic cell-in-cell struc-
tures associate with aggressive behavior of early
OTSCC, targeting such cannibalistic activity might
even form a platform for anti-cancer therapies. Future
studies need to validate the findings of our current
report, preferably in prospective cohorts. After valid-
ation, inclusion of the assessment of cell-in-cell struc-
tures in routine pathology reports should be
considered. Furthermore, the molecular mechanisms
underlying cell-in-cell structures in OTSCC should be
addressed.
Fig. 2 Kaplan-Meier analysis of cell-in-cell structures and patient survival. Cases with cell-in-cell structures associate significantly with a higher rate
of cancer-related mortality (P < 0.001)
Fig. 3 Association of cell-in-cell structures in early OTSCC with
aggressive histopathologic features such as tumor budding (arrow).
This is a deeply invasive tumor (> 4 mm) with a stroma-rich pattern
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